Drug Type ASO |
Synonyms |
Target |
Mechanism Akt-1 inhibitors(Serine/threonine-protein kinase AKT inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Hepatocellular Carcinoma | Phase 2 | CN | 05 Jul 2024 | |
Advanced Malignant Solid Neoplasm | Phase 1 | US | 01 Aug 2022 | |
Hepatocellular Carcinoma | Phase 1 | US | 24 Apr 2021 | |
Hepatocellular Carcinoma | Phase 1 | CN | 24 Apr 2021 |